Ananya Mitra Ph.d., Dabt

Ananya Mitra, Ph.D., DABT has extensive experience in the field of neurology and pharmaceutical research. Ananya is currently the Director of Nonclinical Science at Alector, a position they have held since 2022. Prior to joining Alector, they served as the Associate Director at the same company from 2019 to 2022.

Before their time at Alector, Ananya worked at Adamas Pharmaceuticals, Inc. as an Associate Director of Research from 2015 to 2019. In this role, they conducted nonclinical studies on drug-target interactions, toxicology, and mechanism of action for NDA submission. Ananya also explored new therapeutic indications and managed collaborations with academic groups and CROs.

Ananya also held the position of Head of Scientific Operations - North America at NEUROSERVICE from 2016 to 2017. During this time, they designed preclinical studies in the areas of neurodegeneration, psychiatric diseases, and pain, and developed assays for target validation and mechanism of action.

From 2015 to 2017, Ananya founded and worked as a consultant for NeuroDesign LLC. Here, they focused on study design and experimental oversight for drug discovery in neurological and neurodegenerative diseases.

Ananya's earlier experience includes working as the Director of Pharmacology and Physiology at Circuit Therapeutics, Inc. from 2012 to 2014, where they led preclinical research on gene therapy and medical devices for nervous system disorders. Ananya also served as a Senior Scientist and a postdoctoral scholar at Stanford University School of Medicine, conducting research on neurodegenerative diseases, autoimmune inflammation, and neurotransmitter receptor pharmacology.

Ananya began their career as a Graduate Student at SUNY Buffalo from 2000 to 2005, where they conducted research in their field of specialization.

In summary, Ananya Mitra, Ph.D., DABT is a highly qualified professional with a strong background in neurology, neuropharmacology, and pharmaceutical research. Ananya has held various leadership positions and has significant experience in designing and managing preclinical studies, collaborating with academic and industry partners, and contributing to the development of new therapeutic indications and treatments.

Ananya Mitra, Ph.D., DABT, has a comprehensive education history in the field of neuroscience, molecular physiology, biophysics, and biotechnology. In 1999, they obtained their M.Sc. degree in Biotechnology from Jawaharlal Nehru University (JNU). Following their master's program, from 2000 to 2005, Ananya pursued a Ph.D. in Molecular Physiology and Biophysics at the University at Buffalo. Later, they engaged in post-doctoral training in Cellular and Systems Neuroscience at Stanford University School of Medicine from 2005 to 2008.

Seeking further specialization, Ananya participated in a Summer Neurobiology Course at the Marine Biological Laboratory in 2007. Ananya'sthirst for knowledge and dedication to their field is also evident in their additional certifications. In November 2022, Ananya attained the DABT (Diplomate of the American Board of Toxicology, Inc.) certification, showcasing their expertise and proficiency in the field of toxicology.